NEW YORK, July 30 – MDS Proteomics of Toronto unveiled Monday a new method designed to directly identify known and unknown proteins based on mass spectrometry data.

Using advanced algorithms developed by Matthias Mann, chief proteomics officer of MDS Proteomics, the PepSea technology is designed to identify any protein and to locate and identify the genes the encode the proteins.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.